Los Angeles-Based Pelage Launches Phase 2a Trial: A New Era in Hair Loss Treatment Rooted in Stem Cell Biology
Pelage Pharmaceuticals, based in Los Angeles, has announced the commencement of its Phase 2a clinical trial for a groundbreaking treatment targeting androgenetic alopecia, commonly known as pattern hair loss. This trial marks a significant step in the company's innovative approach to combatting a condition that affects millions globally. Notable for ...
Read moreDetails
